Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance.

Aragri, M; Milana, M; Di Maio, V C; Lenci, I; Carioti, L; Perno, C F; Svicher, V; Angelico, M; Ceccherini-Silberstein, F

Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance.

Aragri, M; Milana, M; Di Maio, V C; Lenci, I; Carioti, L; Perno, C F; Svicher, V; Angelico, M; Ceccherini-Silberstein, F.

Afiliación

Aragri M; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Milana M; Hepatology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.
Di Maio VC; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Lenci I; Hepatology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.
Carioti L; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Perno CF; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.
Svicher V; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Angelico M; Hepatology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.
Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. Electronic address: ceccherini@med.uniroma2.it.

Clin Microbiol Infect ; 26(9): 1266-1268, 2020 Sep.

Article en En | MEDLINE | ID: mdl-32240711

Asunto(s)

Ácidos Aminoisobutíricos/uso terapéutico; Antivirales/uso terapéutico; Bencimidazoles/uso terapéutico; Ciclopropanos/uso terapéutico; Hepacivirus/genética; Hepatitis C/tratamiento farmacológico; Lactamas Macrocíclicas/uso terapéutico; Leucina/análogos & derivados; Prolina/análogos & derivados; Quinoxalinas/uso terapéutico; Sofosbuvir/uso terapéutico; Sulfonamidas/uso terapéutico; Quimioterapia Combinada; Genotipo; Hepacivirus/efectos de los fármacos; Hepatitis C/diagnóstico; Hepatitis C/virología; Humanos; Leucina/uso terapéutico; Masculino; Persona de Mediana Edad; Prolina/uso terapéutico; Pirrolidinas; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Quinoxalinas / Sulfonamidas / Bencimidazoles / Prolina / Hepatitis C / Hepacivirus / Ciclopropanos / Lactamas Macrocíclicas / Sofosbuvir Tipo de estudio: Diagnostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google